Abstract
The effects of drugs acting on muscarinic cholinergic receptors on the catalepsy, antinociception and changes in rectal temperature and in brain dopamine metabolism induced by morphine were studied in Wistar rats. Scopolamine (0.3–30 mg/kg) was about three times as potent as atropine (1–30 mg/kg) in potentiating the cataleptic effect of morphine. Methylscopolamine and methylatropine did not alter the cataleptic effect of morphine. Pilocarpine (100 mg/kg) and arecoline (10 mg/kg) slightly but significantly and RS86 (20–40 mg/kg) clearly antagonized the morphine-catalepsy. RS86 antagonized the atropineinduced potentiation of morphine catalepsy. The antinocieptive effect of pilocarpine was additive and that of RS86 less than additive with morphine. The antimuscarinic compounds did not alter the antinociceptive effect of morphine. Antimuscarinic compounds enhanced the hypothermic effect of morphine, but none of the compounds studied altered the hyperthermic effect of morphine. The antimuscarinic drugs reduced the concentration of striatal homovanillic acid (HVA) in about same proportion in control and morphine-treated rats. Both the muscarinic compounds and morphine increased the concentration of striatal HVA, but when combined their effects were not significantly different from those of inorphine alone. Scopolamine antagonized and pilocarpine accelerated the morphine-induced increase in the rate of depletion of cerebral dopamine content. The present results show that the effects of muscarinic and antimuscarinic cholinergic drugs on the cataleptic effect of morphine were opposite to their effects on the catalepsy induced by neuroleptic compounds.
Similar content being viewed by others
References
Ahtee, L.: Effect of cholinergic drugs on methadone-induced catalepsy and stereotypies in rats treated chronically with methadone. Europ. J. Pharmacol. 39, 203–213 (1976)
Ahtee, L., Kaakkola, S.: Effects of drugs acting on cholinergic receptors on the catalepsy and stereotypies induced by morphine and methadone in rats. Satellite Symposium to 6th Internat. Congress of Pharmacology, Abstracts, pp. 20–21, Espoo, July 18–20, 1975
Ahtee, L., Kääriäinen, I.: The effect of narcotic analgesics on the homovanillic acid content of rat nucleus caudatus. Europ. J. Pharmacol. 22, 206–208 (1973)
Ahtee, L., Kääriäinen, I.: The role of dopamine in pilocarpineinduced catalepsy. Naunyn-Schmiedeberg's Arch. Pharmacol. 284, 25–38 (1974)
Ahtee, L., Kääriäinen, I., Paasonen, M. K.: Effect of nalorphine and antiparkinsonian drugs on methadone-induced rigidity; relation to homovanillic acid content of nucleus caudatus. Ann. Med. exp. Fenn. 50, 180–185 (1972)
Andén, N.-E.: Effects of oxotremorine and physostigmine on the turnover of dopamine in the corpus striatum and the limbic system. J. Pharm. Pharmacol. 26, 738–740 (1974)
Andén, N.-E., Bédard, P.: Influences of cholinergic mechanisms on the function and turnover of brain dopamine. J. Pharm. Pharmacol. 23, 460–462 (1971)
Bartholini, G., Pletscher, A.: Atropine-induced changes of cerebral dopamine turnover. Experientia (Basel) 27, 1302–1303 (1971)
Cashin, C. H., Sutton, S.: The effect of anti-Parkinson drugs on catalepsy induced by α-methyl-p-tyrosine in rats pretreated with intraventricular 6-hydroxydopamine. Brit. J. Pharmacol. 47, 658P-659P (1973)
Corrodi, H., Fuxe, K., Hammer, W., Sjöqvist, F., Ungerstedt, U.: Oxotremorine and central monoamine neurons. Life Sci. 6, 2557–2566 (1967)
Corrodi, H., Fuxe, K., Lidbrink, P.: Interaction between choliergic and catecholaminergic neurons in rat brain. Brain Res. 43, 397–416 (1972)
Costall, B., Naylor, R. J.: Modification of amphetamine effects by intracerebrally administered anticholinergic agents. Life Sci. 11, 239–253 (1972)
Costall, B., Naylor, R. J.: Neuroleptic and non-neuroleptic catalepsy. Arzneimittel-Forsch 23, 674–683 (1973)
Dahlström, B., Paalzow, G., Paalzow, L.: A pharmacokinetic approach to morphine analgesia and its relation to regional turnover of rat brain catecholamines. Life Sci 17, 11–16 (1975)
Evans, W. O.: A new technique for the investigation of some analgesic drugs on a reflexive behavior in the rat. Psychopharmacologia (Berl.) 2, 318–325 (1961)
Friedman, A., Everett, G. M.: Pharmacological aspects of parkinsonism. In: Advances in pharmacology, Vol. 3, S. Garattini and P. A. Shore, eds., pp. 83–127. New York-London: Academic Press 1964
Fukui, K., Takagi, H.: Effect of morphine on the cerebral contents of metabolites of dopamine in normal and tolerant mice: its possible relation to analgesic action. Brit. J. Pharmacol. 44, 45–51 (1972)
Gunne, L. M., Jonsson, J., Fuxe, K.: Effects of morphine intoxication on brain catecholamine neurons. Europ. J. Pharmacol 5, 338–342 (1969)
Herz, A.: Über die Beeinflussung zentral dämpfender und erregender Morphinwirkungen durch Anticholinergica, Nicotinolytica und Antihistaminica an der Ratte. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 241, 236–253 (1961)
Herz, A.: Wirkungen des Arecolins auf das Zentralnervensystem. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 242, 414–429 (1962)
Herz, A., Metyš, J.: Inhibition of nociceptive responses by substances acting on central cholinoceptive systems. In: Pain, A. Soulairac, J. Cahn, and J. Charpentier, eds., pp. 321–334. New York-London: Academic Press 1968
Houser, V. P., Van Hart, D. A.: The effects of scopolamine and pilocarpine upon the aversive threshold of the rat. Pharmacol. Biochem. Behav. 1, 427–431 (1973)
Howes, J. F., Harris, L. S., Dewey, W. L., Voyda, C. A.: Brain acetylcholine levels and inhibition of the tail-flick reflex in mice. J. Pharmacol. exp. Ther. 169, 23–28 (1969)
Ireson, J. D.: A comparison of the antinociceptive actions of cholinomimetic and morphine-like drugs. Brit. J. Pharmacol. 40, 92–101 (1970)
Jacob, J., Barthelemy, C.: Antinociceptive effects of morphine and central cholinergic systems. In: Pain, R. Janzen, W. D. Keidel, A. Herz, and C. Steichele, eds., pp. 236–239, Stuttgart: Thieme 1972
Kaakkola, S., Ahtee, L.: Effect of anticholinergics and cholinomimetics on morphine-catalepsy in rats. 6th Internat. Congress of Pharmacology, Abstracts, p. 270, Helsinki, Finland, July 20–25, 1975
Koelle, G. B.: Parasympathomimetic agents. In: The pharmacological basis of therapeutics, 5th ed., L. S. Goodman and A. Gilman, eds., pp. 467–476, New York: MacMillan 1975
Kuschinsky, K.: Evidence that morphine increases dopamine utilization in corpora striata of rats. Experientia (Basel) 29, 1365–1366 (1973)
Kuschinsky, K.: Are cholinergic mechanisms involved in morphine effects on motility? Naunyn-Schmiedeberg's Arch. Pharmacol. 281, 167–173 (1974)
Kuschinsky, K., Hornykiewicz, O.: Morphine catalepsy in the rat: relation to striatal dopamine metabolism. Europ. J. Pharmacol. 19, 119–122 (1972)
Kääriäinen, I., Vikberg, P.: Effects of aminooxyacetic acid and baclofen on catalepsy, striatal homovanillic acid increase and antinociception caused by methadone in rats. Acta pharmacol. (Kbh.) 39, 536–544 (1976)
Laverty, R., Sharman, D. F.: Modification by drugs of the metabolism of 3,4-dihydroxyphenylethylamine, noradrenaline and 5-hydroxytryptamine in the brain. Brit. J. Pharmacol. 24, 759–772 (1965)
Lotti, V. J.: Body temperature responses to morphine. In: The pharmacology of thermoregulation. Symp., E. Schönbaum and P. Lomax, eds., pp. 382–394. Basel: Karger 1973
Morpurgo, C.: Effects of antiparkinson drugs on phenthiazineinduced catonic reaction. Arch. int. Pharmacodyn. 137, 84–90 (1962)
Nose, T., Takemoto, H.: Effect of oxotremorine on homovanillic acid concentration in the striatum of the rat. Europ. J. Pharmacol. 25, 51–55 (1974)
O'Keeffe, R., Sharman, D. F., Vogt, M.: Effect of drugs used in psychoses on cerebral dopamine metabolism. Brit. J. Pharmacol. 38, 287–304 (1970)
Parkes, M. W.: An examination of central actions characteristic of scopolamine: comparison of central and peripheral activity in scopolamine, atropine and some synthetic basic esters. Psychopharmacologia (Berl.) 7, 1–19 (1965)
Perez-Cuet, J., DiChiara, G., Gessa, G. L.: Accelerated synthesis of dopamine in the rat brain after methadone. Experientia (Basel) 28, 926 (1972)
Pleuvry, B. J., Tobias, M. A.: Comparison of the antinociceptive activities of physostigmine, oxotremorine and morphine in the mouse. Brit. J. Pharmacol. 43, 706–714 (1971)
Portig, P. J., Sharman, D. F., Vogt, M.: Release by tubocurarine of dopamine and homovanillic acid from the superfused caudate nucleus. J. Physiol. (Lond.) 194, 565–572 (1968)
Puri, S. K., Reddy, C., Lal, H.: Blockade of central dopaminergic receptors by morphine: effect of haloperidol, apomorphine or benztropine. Res. Commun. Chem. Path. Pharmacol. 5, 389–401 (1973)
Sasame, H. A., Perez-Cruet, J., DiChiara, G., Tagliamonte, A., Tagliamonte, P., Gessa, G. L.: Evidence that methadone blocks dopamine receptors in the brain. J. Neurochem. 19, 1953–1957 (1972)
Sharman, D. F.: A discussion of the modes of action of drugs which increase the concentration of 4-hydroxy-3-methoxyphenylacetic acid (homovanillic acid) in the striatum of the mouse. Brit. J. Pharmacol. 30, 620–626 (1967)
Shellenberger, M. K., Gordon, J. H.: A rapid, simplified procedure for simultaneous assay of norepinephrine, dopamine and 5-hydroxytryptamine from discrete brain areas. Analyt. Biochem. 39, 356–372 (1971)
Simon, P., Malatray, J., Boissier, J. R.: Antagonism by amantadine of prochlorpemazine-induced catalepsy. J. Pharm. Pharmacol. 22, 546–547 (1970)
Smelik, P. G., Ernst, A. M.: Role of nigro-neostriatal dopaminergic fibres in compulsive gnawing behavior in rats. Life Sci. 5, 1485–1488 (1966)
Stadler, H., Lloyd, K. G., Gadea-Ciria, M., Bartholini, G.: Enhanced striatal acetylcholine release by chlorpromazine and its reversal by apomorphine. Brain Res. 55, 476–480 (1973)
Sugrue, M. F.: The effects of acutely administered analgesics on the turnover of noradrenaline and dopamine in various regions of the rat brain. Brit. J. Pharmacol. 52, 159–165 (1974)
Takemori, A. E., Tulunay, F. C., Yano, I.: Differential effects on morphine analgesia and naloxone antagonism by biogenic amine modifiers. Life Sci. 17, 21–28 (1975)
Tulunay, F. C., Yano, I., Takemori, A. E.: The effect of biogenic amine modifiers on morphine analgesia and its antagonism by naloxone. Europ. J. Pharmacol 35, 285–292 (1976)
Van Eick, A. J., Bock, J.: Comparison of analgesic, cholinomimetic, anticholinergic and sympathomimetic drugs by means of the hot-plate test. Arch. int. Pharmacodyn. 189, 384–387 (1971)
Zetler, G.: Cataleptic state and hypothermia in mice, caused by central cholinergic stimulation and antagonized by anticholinergic and antidepressant drugs. Int. J. Neuropharmacol 7, 325–335 (1968)
Yaksh, T. L., Yamamura, H. I.: Blockade by morphine of acetylcholine release from the caudate nucleus in the mid-pontine pretrigeminal cat. Brain Res 83, 520–524 (1975)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kaakkola, S., Ahtee, L. Effect of muscarinic cholinergic drugs on morphine-induced catalepsy, antinociception and changes in brain dopamine metabolism. Psychopharmacology 52, 7–15 (1977). https://doi.org/10.1007/BF00426593
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00426593